A Phase I/II Study Combining Sunitinib with Standard Ara-C/Daunorubicin Chemotherapy In Patients 60 Years or Older with FLT3 Mutated AML

作者:Fiedler Walter; Krauter Juergen; Goetze Katharina; Salih Helmut R; Bokemeyer Carsten; Spaeth Daniela; Doehner Konstanze; Doehner Hartmut; Schlenk Richard F
来源:52nd Annual Meeting of the American-Society-of-Hematology (ASH), 2010-12-04 to 2010-12-07.
  • 出版日期2010-11-19